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Implementation of a flagship  
PMTCT programme in 
Khayelitsha
Great progress has been made in the prevention 
of mother-to-child transmission (PMTCT) of 
HIV in the past ten years in South Africa, and this is reflected 
in the achievements of the health services in Khayelitsha. 
Located 56 km from the centre of Cape Town, Khayelitsha has 
an estimated population of 500 000, with a 38% unemployment 
rate. Forty-five per cent of the population live in formal housing. 
Antenatal (ANC) HIV seroprevalence increased from 19.3% in 
2000 to 37% in 2011 and is the highest in the Western Cape.[1]
The Provincial Government of the Western Cape (PGWC) 
started the first PMTCT programme in South Africa in Khaye-
litsha as a primary-healthcare-level demonstration project on 
4 January 1999, despite opposition by the National Ministry of 
Health. The School of Public Health and Family Medicine at the 
University of Cape Town was tasked with the monitoring of this 
pilot, and in September 1999, Médecins Sans Frontières (MSF) 
added technical support. Voluntary counselling and testing (VCT) 
was provided at one midwife obstetric unit (MOU) and short-
course zidovudine (AZT) was dispensed by midwives from 36 
weeks of gestation and during labour. Later the pilot was extended 
to a second MOU, and in 1999, 74% of pregnant women agreed to 
testing and 16% were found to be HIV-infected.[2] 
Initially, antiretrovirals were provided only to prevent 
transmission to the child. Maternal AZT was stopped after 
delivery and no further HIV services were available for treating 
the mother. Continuity of care was poor as ANC and postnatal 
child health services were fragmented and provided by different 
health authorities. A clinician at the time recalled, ‘On learning 
they were HIV-positive, women would commonly ask, “When 
am I going to die?” All we had to offer was treatment to reduce 
the risk of the baby being infected, but no treatment to keep the 
mother alive, to see her child grow up.’
After complex negotiations in February 2000, MSF opened 
the first service for pregnant, HIV-infected women requiring 
antiretroviral therapy (ART) in Site B. MSF extended the HIV 
services and ART to everyone who was eligible, according to 
World Health Organization (WHO) guidelines, and to two 
further sites in Khayelitsha. However, legal and regulatory 
barriers to generic antiretroviral imports delayed service 
implementation and drug supplies until 2001. Postnatal women 
from the PMTCT programme initially constituted the majority 
of ART referrals.[3] Nine postnatal clinics provided free formula 
milk for those who elected to perform replacement feeding.[2,4] 
Despite scientific evidence on the effectiveness of PMTCT, the 
AIDS-denialist views of President Thabo Mbeki and Health 
Minister Manto Tshabalala-Msimang led to a significant delay in 
the development of the national PMTCT programme, resulting 
in thousands of infant infections and subsequent deaths. In a 
landmark court case brought against the government by the 
Treatment Action Campaign (TAC), nevirapine (NVP) was 
made available nationally by order of the Constitutional Court 
in 2002 and a national PMTCT programme was implemented. 
NVP was the regimen established in two ‘pilot sites’ per 
province. The implementation of the national programme 
was slow, with wide geographical variation. By this time, the 
Khayelitsha PMTCT sites were well established, and VCT 
coverage was over 95%.[3]
Implementation of more 
efficacious PMTCT regimens
The Western Cape was also the first to launch a province-wide 
PMTCT programme by 2002/2003. Faced with a difficult choice 
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between national policy at that time (single-dose NVP) and the more 
complex regimens, such as AZT from 28 weeks of gestation with the 
addition of single-dose NVP, a technical meeting was held with policy 
makers, researchers and clinicians, including representation from the 
Perinatal HIV Research Unit (PHRU) and the French National Agency 
for AIDS Research (ANRS). It was decided that both interventions 
were equally effective. The MSF-supported Khayelitsha sites moved to 
the more complex regimen in 2003, consisting of AZT from 28 weeks 
of gestation and single-dose NVP given to all HIV-positive mothers in 
labour and to infants post delivery. The effectiveness of this programme 
at a primary care level was demonstrated in Khayelitsha in 2004, 
when PMTCT coverage was reported to be 77% and mother-to-child 
transmission 8.8%. [5] 
While the national PMTCT programme continued to supply single-
dose NVP for pregnant women, the Western Cape provided both AZT 
and NVP in 2004 and enhanced the PMTCT programme by expanding 
it throughout the province as a nurse-driven service within ANC 
services and the MOUs. Lessons learnt from programme implement-
ation assisted the early development of ART services for adults and 
children in the province.[6] Following delivery, women were referred to 
the three MSF-supported ART sites in Khayelitsha, and new sites were 
established in 2003 in Khayelitsha, Langa and Gugulethu, in addition to 
secondary and tertiary facilities. When the national provision of ART 
was announced in 2004, organisations within the Western Cape had 
already changed priorities from demonstrating feasibility to targeting 
scale up and service integration.
Towards an integrated model of care 
for pregnant women requiring ART
In 2004, the Western Cape PMTCT protocols were changed to include 
CD4+ count testing and referral of pregnant women with a CD4+ count 
≤200 cells/µl, or WHO stage 4, defining conditions for ART initiation. 
The treatment and care of pregnant women with advanced disease had 
been a part of global PMTCT strategy since 2002, yet there was little 
evidence on the best approach for implementing ART for pregnant 
women within vertical ANC services in resource-poor settings. 
Integrating the initiation of life-long ART in pregnant women into 
ANC services at a primary care level posed several challenges, including 
laboratory monitoring requirements, multiple ANC visits, linkage to 
postpartum ART, and clinical skills to manage both pregnancy and HIV. 
Initially, pregnant women were referred to an existing ART clinic 
before delivery. However, many women failed to link to care or did 
not receive ART timeously. Patients also complained of the burden 
of additional visits to fetch their treatment, as well as of transport 
challenges. MSF thus began a pilot project to initiate eligible pregnant 
women on ART within two Khayelitsha MOUs in December 2004. This 
provided a fast-track system that streamlined services for providers 
and clients, and allowed late presenters to be initiated on ART within 
a week. Incorporating ART services within the ANC service was 
uncommon at the time, but it decreased loss to follow-up and limited 
delays by removing complex referral processes between facilities. 
Pregnant women with a CD4+ count ≤200 cells/µl were fast-tracked 
for ART through weekly preparation visits, which included intensified 
adherence counselling and routine ART work-up. MSF trained and 
supported a midwife, an enrolled nurse, counsellors, and an outreach 
team of two obstetric medical officers provided by MSF and Mowbray 
Maternity Hospital (MMH).[7] 
Implementation of NIMART in pregnancy
There were a number of challenges associated with the provision 
of ART within MOUs, including staff shortages and turnover that 
required human resource planning and training. Visiting community 
obstetricians from MMH did not get involved in ART provision, as 
few were experienced in prescribing ART. The integration model 
demonstrated functional separation, as a vertical ART initiation service 
was provided by a medical officer in a separate room in the MOU on 
specific days of the week. 
Midwife-managed ART initiation had been the objective of the 
integrated MOU model, but it took six years to achieve this, despite 
well-managed and effective nurse-driven ART services at adjoining 
ART clinics. Staff saw the provision of ART at the ANC consultation as 
an extra task to perform in an already busy service. However, a different 
approach was required when new national guidelines were released 
in 2010. The CD4+ threshold for eligibility for ART was raised (to 
350 cells/µl), thus increasing the proportion of women who qualified 
for ART in pregnancy. This required task shifting and extending the 
prescribing capacity of midwives from dual regimens to providing ART.
Following a successful pilot of nurse-driven ART in Lusikisiki and 
Lesotho, where there was a scarcity of doctors,[8] MSF partnered 
with the PGWC to implement a nurse-initiated management of ART 
(NIMART) mentorship programme in Khayelitsha in December 2011, 
with the first NIMART-trained midwives providing ART at the Site B 
MOU in May 2012. Early on, midwives were initiating 95% of clients 
within a week of first presentation.[9] There was strong support from 
midwives, and facility, programme and sub-district managers, and HIV 
integration and NIMART became policy. Midwives were excited by the 
NIMART training: ‘For me, NIMART is very interesting, in that it’s not 
something you do as a midwife. It puts you on another level. You see a 
patient; you diagnose and manage them. This is not what I was doing 
in the labour ward. I learnt a lot – about HIV, the drugs, everything.’
Implementing Option B+ in Khayelitsha
The announcement on World AIDS Day in 2012 that South Africa would 
shift from Option A (AZT for women with a CD4+ count >350 cells/µl) to 
Option B (ART for all pregnant and breastfeeding women irrespective of 
CD4+ count), highlighted the importance of NIMART mentorship for nurse 
midwives and ANC nurses. In July 2013, the Site B MOU in Khayelitsha 
implemented Option B+ (life-long ART for pregnant and breastfeeding 
women), including fixed-dose combinations, a new counselling model 
to support same-day initiation, and more attention to viral load (VL) 
monitoring in pregnancy, using VL as a predictor of transmission. 
The rationale behind the introduction of Option B+ was not only to 
prevent the transmission of HIV to the infant, but to create an entry 
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point for lifelong ART care for women and their families. With this 
change, the linkage of HIV-exposed infants to care, retention in care 
for mothers receiving ART, as well as the provision of services which 
cater for male partners’ needs have become even more of a priority. The 
implementation of Option B+ has been remarkably smooth. Since 1 July 
2013, an average of 70 - 80 women have been initiated on ART monthly 
at the Site B MOU, and less than five women have refused to initiate 
treatment during this time. The fixed-dose combinations (FDCs) have 
made it easier for both staff and women. The adaptation of adherence 
counselling has led to shorter sessions that allow for same-day initiation, 
with increased post-initiation counselling being piloted in Khayelitsha. 
Despite the increased workload, midwives feel empowered and are 
passionate about their new role: ‘Nowadays we manage their pregnancy 
and we also manage their HIV. I’m so committed that I don’t care if I’m 
the one who leaves last – I don’t mind. As long as I leave after seeing that 
every women who is eligible is initiated.’
The new challenge is to retain women on ART and achieve sustained 
virological suppression. An evaluation of the Option B+ programme is 
underway to study these outcomes. As more women who enter ANC 
services are already receiving ART (a quarter of the monthly new ANC 
attendees with HIV), an adapted model to prevent, detect and manage 
treatment failure is needed. 
Conclusion
A large part of the success of the PMTCT programme in Khayelitsha has 
been due to progressive provincial policies, and a successful partnership 
between the provincial and local authority health services, academic 
institutions and non-governmental organisations such as MSF and 
the TAC, as well as dedicated managers and staff. Khayelitsha is a 
severely disadvantaged and resource-limited area, and yet the PMTCT 
programme has remained at the forefront of innovation and has evolved 
in line with advances in global best practice in ART care. There is hope 
that in the not-too-distant future, paediatric HIV infection will become 
a disease of the past, read about in textbooks. 
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